These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28289244)

  • 21. A population genetics perspective on the determinants of intra-tumor heterogeneity.
    Hu Z; Sun R; Curtis C
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):109-126. PubMed ID: 28274726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolutionary dynamics and significance of multiple subclonal mutations in cancer.
    Beckman RA; Loeb LA
    DNA Repair (Amst); 2017 Aug; 56():7-15. PubMed ID: 28652129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evolutionary stability perspective on oncogenesis control in mature T-cell populations.
    Diebner HH; Kirberg J; Roeder I
    J Theor Biol; 2016 Jan; 389():88-100. PubMed ID: 26549469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer.
    Sameen S; Barbuti R; Milazzo P; Cerone A; Del Re M; Danesi R
    J Theor Biol; 2016 Jan; 389():263-73. PubMed ID: 26551156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered Micro-RNA Degradation Promotes Tumor Heterogeneity: A Result from Boolean Network Modeling.
    Wu Y; Krueger GR; Wang G
    Anticancer Res; 2016 Feb; 36(2):575-81. PubMed ID: 26851011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible roles of mechanical cell elimination intrinsic to growing tissues from the perspective of tissue growth efficiency and homeostasis.
    Lee SW; Morishita Y
    PLoS Comput Biol; 2017 Jul; 13(7):e1005651. PubMed ID: 28704373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic clonal evolution: A selection-centric perspective.
    Scott J; Marusyk A
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):139-150. PubMed ID: 28161395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism?
    Chinnery PF; Samuels DC; Elson J; Turnbull DM
    Lancet; 2002 Oct; 360(9342):1323-5. PubMed ID: 12414225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-cell communication in carcinogenesis.
    Trosko JE; Ruch RJ
    Front Biosci; 1998 Feb; 3():d208-36. PubMed ID: 9458335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution.
    Ibrahim-Hashim A; Robertson-Tessi M; Enriquez-Navas PM; Damaghi M; Balagurunathan Y; Wojtkowiak JW; Russell S; Yoonseok K; Lloyd MC; Bui MM; Brown JS; Anderson ARA; Gillies RJ; Gatenby RA
    Cancer Res; 2017 May; 77(9):2242-2254. PubMed ID: 28249898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational modeling in melanoma for novel drug discovery.
    Pennisi M; Russo G; Di Salvatore V; Candido S; Libra M; Pappalardo F
    Expert Opin Drug Discov; 2016 Jun; 11(6):609-21. PubMed ID: 27046143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
    Verkhivker GM
    Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations.
    Rozhok AI; DeGregori J
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):8914-21. PubMed ID: 26195756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution.
    Ling S; Hu Z; Yang Z; Yang F; Li Y; Lin P; Chen K; Dong L; Cao L; Tao Y; Hao L; Chen Q; Gong Q; Wu D; Li W; Zhao W; Tian X; Hao C; Hungate EA; Catenacci DV; Hudson RR; Li WH; Lu X; Wu CI
    Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6496-505. PubMed ID: 26561581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thinking Cancer.
    Pashov A; Hernandez Puente CV; Ibrahim SM; Monzavi-Karbassi B; Makhoul I; Kieber-Emmons T
    Monoclon Antib Immunodiagn Immunother; 2018 Jun; 37(3):117-125. PubMed ID: 29939836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A system for detecting high impact-low frequency mutations in primary tumors and metastases.
    Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H
    Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The challenges of tumor genetic diversity.
    Mroz EA; Rocco JW
    Cancer; 2017 May; 123(6):917-927. PubMed ID: 27861749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mathematical model with aberrant growth correction in tissue homeostasis and tumor cell growth.
    Zhang H; Zhang M; Lei J
    J Math Biol; 2022 Nov; 86(1):2. PubMed ID: 36436124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of evolving cancers will require dynamic decision support.
    Strobl MAR; Gallaher J; Robertson-Tessi M; West J; Anderson ARA
    Ann Oncol; 2023 Oct; 34(10):867-884. PubMed ID: 37777307
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.